Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
130 Results Found
FDA: Record number of generic drugs approved in FY 2019
The Food and Drug Administration approved a record high 1,171 generic drugs in fiscal year 2019, the agency said today.
AHA, others comment to DEA on controlled substances quotas
The AHA and six other organizations today submitted comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.
Civica Rx Delivers First Generic Drug
In what is being hailed as a model for provider-led innovation, Civica Rx, the startup formed last year by a group of health systems to combat rising drug prices and shortages of drugs long on the market, recently made its first delivery of generic medications to a hospital.
FDA authorizes new treatment for migraine
The Food and Drug Administration Oct. 11 approved a new tablet for the acute treatment of migraine headache pain.
AHA comments to DEA on 2020 controlled substances quotas
The AHA today urged the Drug Enforcement Administration to explicitly consider drug shortages when setting and adjusting aggregate production quotas, citing concern that the agency’s proposal to reduce 2020 production quotas for five opioid controlled substances would exacerbate shortages of injectable opioid medications.
AHA Comments on DEA’s Proposed Aggregate Production Quotas for Controlled Substances, Schedule I and II
The AHA appreciates the opportunity to comment on the Drug Enforcement Administration’s proposed notice on aggregate production quotas for schedule I and II controlled substances.
AHA comments to DEA on 2019 controlled substances quotas
The AHA Aug. 28 urged the Drug Enforcement Administration to reconsider its proposed 2019 aggregate production quotas for certain controlled substances, which the agency said would reduce manufacturing quotas for six frequently misused opioids by an average 10 percent.
Congress urges FDA action to address drug shortages
A bipartisan group of 92 members of Congress yesterday urged the Food and Drug Administration to prioritize the release of an interagency task force report on the root causes of drug shortages and recommendations to address them.
DEA proposes reducing five opioid production quotas for 2020
The Drug Enforcement Administration this week proposed reducing aggregate production quotas for five opioid controlled substances in 2020.
Survey: Drug shortages cost hospitals $360M annually
Hospitals spend close to $360 million each year to manage drug shortages, according to a study released this week by Vizient Inc.